The Journal of Pathology 2022

4 papers
In 2022, research published in The Journal of Pathology emphasized the integration of computational tools and artificial intelligence into diagnostic workflows. A significant portion of the work focused on digital pathology, including the use of computer-extracted nuclear morphology features to differentiate between stage II and IV colon tumors. Other studies explored the application of artificial intelligence to identify genetic alterations within conventional histopathology images. These efforts reflect a broader trend toward enhancing traditional diagnostic methods with automated, data-driven analysis. The year’s edition also featured investigations into the molecular drivers of cancer and the identification of therapeutic biomarkers. Research utilizing mouse models examined how the genetic context of oncogenic drivers dictates the development of vascular sarcoma. Additionally, studies identified nuclear pCHK1 as a potential biomarker for determining sensitivity to ATR inhibition. Notable contributors to these findings included Anant Madabhushi, Jakob Nikolas Kather, and Joseph Willis. Collectively, the 2022 papers demonstrate a focus on refining cancer staging and personalizing treatment through both molecular biology and computational innovation.

Top Research Directions

The 6 research directions with The Journal of Pathology 2022 papers, ranked by paper count, next to 2021. Share is the fraction of the edition’s papers in the direction.

#Direction20222021Share 2022Share 20212021 rank
1Composite Multi-Marker Diagnostic Panels1025.0%0.0%—
2Image Based Morphological Profiling of Cellular States1025.0%0.0%—
3Molecular Switches Regulating DNA Repair Machinery Recruitment1025.0%0.0%—
4Quantitative Geometric Descriptors for Medical Risk Stratification1025.0%0.0%—
5Statistical Feature Pruning via Correlation Analysis1025.0%0.0%—
6Visualizing Subcellular Localization with Fluorescent Fusion Proteins1025.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Journal of Pathology 2022 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 2 credited papers.

#InstitutionPapersShare20212021 rank
101gc0wp38 150.0%0—
2025yypj46 150.0%0—
303yky5015 150.0%0—
4Alberta Machine Intelligence Institute 150.0%0—
5Bayer (Germany) 150.0%0—
6Case Western Reserve University 150.0%0—
7National University of Singapore 150.0%0—
8University of Alberta 150.0%0—

Download all institutions as CSV

About this data

Papers. The Journal of Pathology 2022 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2021 use shares, since the edition went from 9 to 4 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 4 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Journal of Pathology 2022”, https://lacuna.tiptreesystems.com/venue/the-journal-of-pathology/2022.

Top Authors

AuthorPapers
Jakob Nikolas Kather1

Papers

Title
Artificial intelligence to identify genetic alterations in conventional histopathology
Computer‐extracted features of nuclear morphology in hematoxylin and eosin images distinguish <scp>s</scp>tage <scp>II</scp> and <scp>IV</scp> colon tumors
Genetic context of oncogenic drivers dictates vascular sarcoma development in <scp>aP2‐Cre</scp> mice
Nuclear <scp>pCHK1</scp> as a potential biomarker of increased sensitivity to <scp>ATR</scp> inhibition